DLG4, discs large MAGUK scaffold protein 4, 1742

N. diseases: 91; N. variants: 54
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0525045
Disease: Mood Disorders
Mood Disorders
0.330 Biomarker group BEFREE We found the transcript levels of GABA(A) receptor beta 2 (GABRB2) and post-synaptic density-95 (PSD-95) to be significantly decreased in the ACC in mood disorder. 22357337 2012
CUI: C0525045
Disease: Mood Disorders
Mood Disorders
0.330 Biomarker group PSYGENET We found the transcript levels of GABA(A) receptor beta 2 (GABRB2) and post-synaptic density-95 (PSD-95) to be significantly decreased in the ACC in mood disorder. 22357337 2012
CUI: C0525045
Disease: Mood Disorders
Mood Disorders
0.330 Biomarker group PSYGENET Abnormal expression of SAP-102 in schizophrenia and SAP-102 and PSD-95 in mood disorders in subcortical structures receiving afferent glutamatergic innervation from frontal cortex suggests dysregulation of cortical-subcortical circuitry in these illnesses. 16023328 2005
CUI: C0525045
Disease: Mood Disorders
Mood Disorders
0.330 Biomarker group BEFREE Abnormal expression of SAP-102 in schizophrenia and SAP-102 and PSD-95 in mood disorders in subcortical structures receiving afferent glutamatergic innervation from frontal cortex suggests dysregulation of cortical-subcortical circuitry in these illnesses. 16023328 2005
CUI: C0525045
Disease: Mood Disorders
Mood Disorders
0.330 Biomarker group PSYGENET Abnormalities of PSD95-like molecules and other intracellular signaling machinery may contribute to dysregulated communication between multiple neurotransmitter systems (such as glutamatergic and dopaminergic systems) that are potentially involved in the neurobiology of schizophrenia and affective disorders. 15054476 2004
CUI: C0525045
Disease: Mood Disorders
Mood Disorders
0.330 Biomarker group BEFREE Abnormalities of PSD95-like molecules and other intracellular signaling machinery may contribute to dysregulated communication between multiple neurotransmitter systems (such as glutamatergic and dopaminergic systems) that are potentially involved in the neurobiology of schizophrenia and affective disorders. 15054476 2004